NCT01885182 2019-10-04Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer PainMundipharma (China) Pharmaceutical Co. LtdPhase 3 Completed232 enrolled 16 charts